XML 55 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Series Seed Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock [Member]
Series B-1 Convertible Preferred Stock [Member]
Series B-2 Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Temporary equity, beginning balance (in share) at Dec. 31, 2021   684,739 2,029,666 1,104,178 223,417        
Temporary equity, beginning balance at Dec. 31, 2021   $ 15,924 $ 77,736 $ 57,703 $ 12,500        
Beginning balance (in share) at Dec. 31, 2021           237,803      
Beginning balance at Dec. 31, 2021 $ (42,208)           $ 1,600 $ (7) $ (43,801)
Issuance of common stock for services rendered (in share)           497      
Issuance of common stock for services rendered 11           11    
Exercises of stock options (in shares)           8,722      
Exercises of stock options 62           62    
Vesting of restricted common stock (in share)           21,377      
Vesting of restricted common stock 5           5    
Stock-based compensation expense 1,129           1,129    
Other comprehensive income 2             2  
Net loss $ (58,032)               (58,032)
Ending balance (in share) at Dec. 31, 2022 268,468         268,399      
Ending balance at Dec. 31, 2022 $ (99,031)           2,807 (5) (101,833)
Temporary equity, beginning balance (in share) at Dec. 31, 2022   684,739 2,029,666 1,104,178 223,417        
Temporary equity, ending balance at Dec. 31, 2022   $ 15,924 $ 77,736 $ 57,703 $ 12,500        
Issuance of common stock for services rendered (in share)           292      
Issuance of common stock for services rendered $ 6           6    
Exercises of stock options (in shares) 39,395         73,394      
Exercises of stock options $ 702           702    
Vesting of restricted common stock (in share)           2,902      
Stock-based compensation expense 2,375           2,375    
Issuance of Series B-2 convertible preferred stock, net of issuance costs (in share)         813,239        
Issuance of Series B-2 convertible preferred stock, net of issuance costs         $ 45,458        
Issuance of common stock for cash in PIPE financing (in share)           2,077,864      
Issuance of common stock for cash in PIPE financing 117,252         $ 2 117,250    
Conversion of preferred stock to common stock (in share)   (684,739) (2,029,666) (1,104,178) (1,036,656) 4,855,208      
Conversion of preferred stock to common stock 209,320 $ (15,924) $ (77,736) $ (57,703) $ (57,958) $ 5 209,315    
Issuance of common stock to Frequency shareholders in reverse recapitalization (in share)           738,457      
Issuance of common stock to Frequency shareholders in reverse recapitalization 32,701         $ 1 32,700    
Reverse recapitalization transaction costs (12,247)           (12,247)    
Other comprehensive income 5             $ 5  
Net loss $ (81,172)               (81,172)
Ending balance (in share) at Dec. 31, 2023 8,016,516         8,016,516      
Ending balance at Dec. 31, 2023 $ 169,911         $ 8 $ 352,908   $ (183,005)
Temporary equity, beginning balance (in share) at Dec. 31, 2023   0 0 0 0        
Temporary equity, ending balance at Dec. 31, 2023   $ 0 $ 0 $ 0 $ 0